Detalles de la búsqueda
1.
EGFR exon 18 delE709_T710insD mutated stage IV non-small cell lung cancer treated with osimertinib: a case report.
Anticancer Drugs
; 2024 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38513159
2.
Tailored immunotherapy approach with nivolumab with or without nivolumab plus ipilimumab as immunotherapeutic boost in patients with metastatic renal cell carcinoma (TITAN-RCC): a multicentre, single-arm, phase 2 trial.
Lancet Oncol
; 24(11): 1252-1265, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37844597
3.
Using the emotional functioning in clinical practice to detect psychological distress in patients with advanced thoracic and colorectal cancer.
Health Qual Life Outcomes
; 21(1): 15, 2023 Feb 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-36800957
4.
Fibrin and Marine-Derived Agaroses for the Generation of Human Bioartificial Tissues: An Ex Vivo and In Vivo Study.
Mar Drugs
; 21(3)2023 Mar 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-36976236
5.
Pembrolizumab versus placebo as adjuvant therapy for completely resected stage IB-IIIA non-small-cell lung cancer (PEARLS/KEYNOTE-091): an interim analysis of a randomised, triple-blind, phase 3 trial.
Lancet Oncol
; 23(10): 1274-1286, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36108662
6.
Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer.
N Engl J Med
; 378(22): 2078-2092, 2018 May 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-29658856
7.
Osimertinib in advanced EGFR-T790M mutation-positive non-small cell lung cancer patients treated within the Special Use Medication Program in Spain: OSIREX-Spanish Lung Cancer Group.
BMC Cancer
; 21(1): 230, 2021 Mar 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33676426
8.
Evaluation of Marine Agarose Biomaterials for Tissue Engineering Applications.
Int J Mol Sci
; 22(4)2021 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33672027
9.
Patient-reported outcomes following pembrolizumab or placebo plus pemetrexed and platinum in patients with previously untreated, metastatic, non-squamous non-small-cell lung cancer (KEYNOTE-189): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial.
Lancet Oncol
; 21(3): 387-397, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32035514
10.
PTEN expression and mutations in TSC1, TSC2 and MTOR are associated with response to rapalogs in patients with renal cell carcinoma.
Int J Cancer
; 146(5): 1435-1444, 2020 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31335987
11.
Randomised Phase II study comparing alternating cycles of sunitinib and everolimus vs standard sequential administration in first-line metastatic renal carcinoma (SUNRISES study).
BJU Int
; 126(5): 559-567, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32654362
12.
Radium-223 international early access program: results from the Spanish subset.
Future Oncol
; 14(1): 41-50, 2018 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-29232987
13.
Impact on clinical practice of the implementation of guidelines for the toxicity management of targeted therapies in kidney cancer. The protect-2 study.
BMC Cancer
; 16: 135, 2016 Feb 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-26906039
14.
The Wide Experience of the Sequential Therapy for Patients with Metastatic Renal Cell Carcinoma.
Curr Oncol Rep
; 18(11): 66, 2016 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-27613167
15.
Management of the adverse events of afatinib: a consensus of the recommendations of the Spanish expert panel.
Future Oncol
; 11(2): 267-77, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25236437
16.
Chemotherapy-associated anemia in patients with lung cancer: an epidemiological, retrospective and multicenter study.
Future Oncol
; 11(11): 1665-74, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26043218
17.
Controversies in the treatment of invasive urothelial carcinoma: a case report and review of the literature.
BMC Urol
; 15: 15, 2015 Mar 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-25887442
18.
Dovitinib versus sorafenib for third-line targeted treatment of patients with metastatic renal cell carcinoma: an open-label, randomised phase 3 trial.
Lancet Oncol
; 15(3): 286-96, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24556040
19.
"Inherited cardiovascular disease mindset" can identify concealed inherited conditions at cardio-oncology evaluation: An opportunistic screening.
Int J Cardiol
; 401: 131825, 2024 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38309590
20.
Blood tumor mutational burden and response to pembrolizumab plus chemotherapy in non-small cell lung cancer: KEYNOTE-782.
Lung Cancer
; 190: 107506, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38422883